D.E. Shaw & Co’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.2M Sell
959,257
-282,364
-23% -$12.5M 0.04% 692
2025
Q4
$51.2M Buy
1,241,621
+107,435
+9% +$4.31M 0.04% 684
2025
Q3
$44M Buy
1,134,186
+342,881
+43% +$11.1M 0.04% 721
2025
Q2
$21.9M Buy
791,305
+393,560
+99% +$10M 0.02% 978
2025
Q1
$8.83M Buy
397,745
+77,738
+24% +$1.6M 0.01% 1489
2024
Q4
$6.33M Sell
320,007
-990
-0.3% -$22.6K 0.01% 1796
2024
Q3
$8.02M Buy
320,997
+151,349
+89% +$3.69M 0.01% 1582
2024
Q2
$3.17M Sell
169,648
-52,205
-24% -$978K ﹤0.01% 2225
2024
Q1
$4.38M Sell
221,853
-82,752
-27% -$1.62M 0.01% 1991
2023
Q4
$5.34M Sell
304,605
-12,914
-4% -$212K 0.01% 1855
2023
Q3
$5.52M Buy
317,519
+78,919
+33% +$1.33M 0.01% 1729
2023
Q2
$3.36M Sell
238,600
-1,188
-0.5% -$15.9K 0.01% 2197
2023
Q1
$2.58M Buy
239,788
+2,343
+1% +$30.9K ﹤0.01% 2491
2022
Q4
$3.56M Buy
237,445
+125,274
+112% +$1.82M 0.01% 2408
2022
Q3
$1.44M Buy
112,171
+69,243
+161% +$789K ﹤0.01% 3293
2022
Q2
$416K Buy
+42,928
New +$401K ﹤0.01% 4205
2022
Q1
Sell
-12,317
Closed -$145K 5782
2021
Q4
$145K Buy
+12,317
New +$151K ﹤0.01% 4978
2021
Q1
Sell
-50,089
Closed -$885K 4295
2020
Q4
$885K Sell
50,089
-52,297
-51% -$919K ﹤0.01% 3094
2020
Q3
$1.57M Buy
102,386
+53,004
+107% +$995K ﹤0.01% 2558
2020
Q2
$1.26M Buy
+49,382
New +$1.03M ﹤0.01% 2768
2019
Q3
Sell
-26,134
Closed -$354K 3941
2019
Q2
$354K Sell
26,134
-69,122
-73% -$1.07M ﹤0.01% 3243
2019
Q1
$1.72M Buy
95,256
+85,714
+898% +$1.66M ﹤0.01% 2267
2018
Q4
$268K Buy
+9,542
New +$199K ﹤0.01% 3413

Other funds holding KNSA